401
Participants
Start Date
July 14, 2020
Primary Completion Date
April 30, 2025
Study Completion Date
October 30, 2025
Control Condition
3 in-person study visits, approximately one hour each. These will take place at baseline, 6 months, and 12 months.
Regret Lottery
"Delivered by the Way to Health platform, installed on a smartphone and communicates with participants via text message.Participants are eligible to receive a potential cash reward if they are adherent with their antihypertensive medication the day before, which is monitored via electronic monitoring device (EMD) from AdhereTech. Each participant is assigned a 2-digit number for the trial, and each day the Way to Health platform randomly generates a 2-digit number. Participants will receive a prize if both digits match (1 in 100 chance) and will receive a prize of lesser value if one digit matches (18 in 100 chance). If they are not adherent with their medication, but would have won if they were adherent, they receive a text message that they would have won (regret component)."
NYU Langone Health, New York
National Heart, Lung, and Blood Institute (NHLBI)
NIH
NYU Langone Health
OTHER